A nurse is providing teaching for a client who has diabetes and a new prescription for insulin glargine. Which of the following instructions should the nurse provide regarding this type of insulin?

Choice A rationale Insulin glargine is classified as a long-acting basal insulin analogue designed to provide a steady level of insulin for an extended period. It typically has an onset of 1.1 hours, no pronounced peak, and a duration of action that lasts between 18 to 24 hours. This pharmacological profile mimics the continuous basal secretion of insulin by a healthy pancreas, which is essential for maintaining stable blood glucose levels between meals and during sleep. Choice B rationale A duration of 14 hours is generally associated with intermediate-acting insulins like NPH, which typically act for 12 to 18 hours, rather than long-acting glargine. Insulin glargine is specifically engineered with a low solubility at a neutral pH, allowing it to form micro-precipitates in the subcutaneous tissue that release slowly over a full day. A 14-hour window would result in a significant gap in basal coverage for a patient requiring 24-hour glycemic control. Choice C rationale A duration of 3 to 6 hours is characteristic of rapid-acting insulins such as lispro, aspart, or glulisine, which are used primarily to manage postprandial glucose spikes. These insulins have a quick onset of 15 minutes and peak within 1 to 2 hours. Using these as a reference for insulin glargine would be incorrect because glargine is meant for long-term stabilization rather than immediate mealtime coverage, and its action is significantly more prolonged. Choice D rationale A duration of 6 to 10 hours is most representative of short-acting regular insulin, which has a total duration of action typically spanning 5 to 7 or 8 hours. Regular insulin is used for bolus coverage during meals or in emergency intravenous scenarios. Glargine’s unique chemical structure ensures a much longer presence in the systemic circulation to maintain a flat, peakless effect, making the 6 to 10-hour timeframe inaccurate for this specific medication.